Refractory Metastatic Digestive System Carcinoma
1 clinical trials · Condition
◉ Watch Refractory Metastatic Digestive System Carcinoma
| Record | Firm | Date |
|---|---|---|
| Trial of Surufatinib Combined With Toripalimab in the Treatment of Peritoneal Metastatic Carcinoma of Gastrointestinal or Primary Peritoneal Cancer (NCT05030246) | Peking University | 2021-07-14 |
Track Refractory Metastatic Digestive System Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.